Moneycontrol Be a Pro
Get App
you are here: HomeNewsBusiness
Last Updated : Oct 30, 2019 07:52 PM IST | Source: Moneycontrol.com

3-Point Analysis | Hikal Q2 review

Sakshi Batra does a 3-Point Analysis to understand Hikal Limited's earnings fine print and the outlook on the company.

Hikal, the emerging pharma and chemicals company, witnessed a catastrophic second quarter, marred by operational challenges. A planned shutdown for its Bengaluru plant was factored in while shutdowns in Mahad and Taloja plants proved to be Black Swan events.

 

Moneycontrol's Sakshi Batra does a 3-Point Analysis to understand the company's earnings fine print and the outlook on the company.

Close
Watch the video for more.

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Oct 30, 2019 07:52 pm
Loading...
Sections
Follow us on
Available On